|
Jun 17
|
Certara (NASDAQ:CERT) Is Reinvesting At Lower Rates Of Return
|
|
Mar 13
|
Arvinas (ARVN) Moves 8.8% Higher: Will This Strength Last?
|
|
Jan 15
|
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
|
|
Oct 2
|
Certara Completes Acquisition of Chemaxon
|
|
Sep 30
|
High Growth Tech Stocks To Watch In September 2024
|
|
Aug 21
|
Certara to Participate in Upcoming Investor Conferences
|
|
Aug 15
|
Certara Launches Phoenix™ Version 8.5 Drug Development Software
|
|
Jul 29
|
Certara (NASDAQ:CERT) Shareholders Will Want The ROCE Trajectory To Continue
|
|
May 9
|
Certara, Inc. (NASDAQ:CERT) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Certara First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 8
|
Q1 2024 Certara Inc Earnings Call
|
|
May 8
|
Certara Inc (CERT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
|
|
May 7
|
Certara, Inc. (CERT) Q1 Earnings Meet Estimates
|
|
May 7
|
Certara Inc (CERT) Q1 2024 Earnings: Mixed Results Amidst Revenue Growth and Net Loss
|
|
May 7
|
Certara Reports First Quarter 2024 Financial Results
|
|
May 6
|
What Makes Certara (CERT) an Attractive Bet?
|
|
Apr 16
|
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
|
|
Apr 9
|
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
|
|
Apr 4
|
Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares
|
|
Apr 1
|
Certara, Inc.'s (NASDAQ:CERT) Intrinsic Value Is Potentially 66% Above Its Share Price
|